Contributors
Sharon Adams(National Institutes of Health Clinical Center), Thomas J. Kunicki(Scripps Research Institute), Cassandra D. Josephson(Emory University), Nancy M. Heddle(McMaster University), Dana V. Devine(University of British Columbia), John R. Hess(Harborview Medical Center), Robert Crookes, Terrence L. Geiger(St. Jude Children's Research Hospital), Elizabeth E. Culler, Richard J. Benjamin(Cerus (United States)), Paul C. Hébert(Bruyère), Jeffrey L. Carson(Rutgers, The State University of New Jersey), James P. AuBuchon(Dartmouth–Hitchcock Medical Center), Howard Benn(Seton Hall University), Steven Kleinman(University of British Columbia), Karen E. King, Melody J. Cunningham, Kenneth C. Anderson(Dana-Farber Cancer Institute), Neil Blumberg(University of Rochester Medical Center), James R. Eckman, Hal E. Broxmeyer(Indiana University – Purdue University Indianapolis), Mindy Goldman(Canadian Blood Services), Eberhard Fiebig, Alexander Duncan, Laurence Corash(Cerus (United States)), Richard M. Kaufman(Dartmouth–Hitchcock Medical Center), Paul V. Holland(Unknown), Ginine M. Beyer(University of Maryland, Baltimore), John M. Fisk, Michael P. Busch(Vitalant), Shealynn B. Harris, Sunny Dzik(Massachusetts General Hospital), Kim Janatpour, Mark E. Brecher, Jon Barrett(Sunnybrook Health Science Centre), Viviana V. Johnson, Sally A. Campbell‐Lee(University of Illinois Chicago), Thomas S. Kickler(Johns Hopkins University), Diane Killion, Jeannie Callum(Sunnybrook Health Science Centre), Kenneth A. Clark(Centers for Disease Control and Prevention), Christopher D. Hillyer(New York Blood Center), Barbara M. Alving(Uniformed Services University of the Health Sciences), Richard J. Davey(St Thomas' Hospital), Nicholas Bandarenko(Duke Medical Center), Joanna M. Heal(University of Rochester), Morris A. Blajchman(McMaster University), Roger Y. Dodd(American Red Cross), A. Bradley Eisenbrey, Krista L. Hillyer(Emory University)
Cited by 1
Related Papers
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
|New England Journal of Medicine|1999|5.2k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma
|JAMA|2015|2.5k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k